Can lab-made blood make up for global shortages? – DW – 06/13/2025
Many countries lack blood donors. The quest to create an artificial, lab-made blood type that could make up for supply shortages is extremely difficult. But there are some technologies that offer hope.
Blood reserves are in short supply around the world. According to the World Health Organization (WHO), blood donation services in many countries are simply unable to meet demands for collecting and storing healthy blood. Germany's Red Cross (DRK) estimates that some 112 million annual donations are required to cover the need. The DRK adds that one blood donation can be enough to help up to three injured or extremely ill patients.
Blood donations, however, vary greatly according to national wealth, with 40% of 118.5 million annual donations coming from high-income countries that make up only 16% of the world's population.
Yet, even wealthy countries constantly need to draw from and replenish their blood banks. Germany alone uses some 15,000 units of blood each day. Often, even promises of money, gifts or vouchers are not enough to encourage donor participation.
Animal blood not (yet) an alternative
Although animal blood could theoretically be used in human transfusions if successfully altered with the use of gene-editing technology, the impediments to getting there are incredibly complex. Animal blood cells are significantly different from human blood cells, especially regarding surface structure.
The human immune system would immediately recognize non-altered animal blood cells as foreign and reject them. That is why all immune-related antigens would have to be removed or human antigens added, a highly complicated procedure. These issues have rendered the potential use of animal blood for human transfusions unrealistic in the near future.
The quest to create a new, universal blood type
At the moment, different approaches to finding a solution to blood shortages are being taken by scientists around the world. Researchers have, for instance, altered blood stem cells, also known as hematopoietic stem cells or HSCs, in ways that allow them to transport more oxygen. They have developed enzymes to neutralize blood type, doing away with the problem of compatibility. Artificial, longer-lasting red blood cells are being developed, too.
But the promise of blood substitutes also comes with considerable risk. Such blood can trigger potentially deadly anaphylactic reactions when, for example, the immune system recognizes foreign enzymes or elements contained in artificial blood. Any such blood substitute must replicate all of the functions of biological blood and be universally compatible — similar to naturally occurring Type O blood, which is considered a "universal donor" type.
What is your blood made of? Where is it formed?
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
The most promising research approaches so far
Several methods for producing lab-made blood are nearly ready for use; others need more trials, including human testing, to ensure such new blood products are safe. Here, a list of five top prospects:
1. Genetically modifying red blood cells
Researchers at Stanford University and the University of California San Francisco (UCSF) have used CRISPR gene-editing technology to develop a new method for altering bone marrow stem cells in a way that increases their production of hemoglobin in red blood cells, allowing these to carry more oxygen.
So far, returns have been modest when compared to biological blood, with researchers only producing roughly 1% of the hemoglobin that a donor would. Still, when the team's trial was completed with no complications or side-effects to participants, it was celebrated as a medical breakthrough.
2. Neutralizing blood type with gut bacteria enzymes
In Denmark and Sweden, scientists have found an enzyme in intestinal bacteria that can remove particular elements from blood cells, namely the ABO blood type antigens that determine the different biological blood groups, among them A and B. When these determiners are removed, blood cells become Type O, meaning they can be used for almost every possible patient.
Still, until now scientists have been unable to remove the determiners in their entirety, leaving small traces behind and thus posing a risk of allergic reaction in some individuals. Another major hurdle is the removal of the so-called rhesus factor — a surface protein key in determining blood compatibility.
3. Nano RBCs: Microscopic artificial blood cells
Researchers at Penn State University in the US are currently producing tiny, artificial red blood cells (RBC) that function just like the real thing. Although nano-RBCs are only one-tenth the size of normal blood cells they can transport just as much oxygen. These little cells are extremely flexible and can even move through small blood vessels. They would also seem ideally suited for emergency situations and natural catastrophes as they can be stored at room temperature for long periods of time.
4. Military application for enhanced performance
The US military is backing research that loads up red blood cells with special nanoparticles. The Pentagon's Defense Advanced Research Projects Agency, better known as DARPA, is creating what it calls a "Red Blood Cell Factory" that will help soldiers cope with lack of oxygen at altitude, in extreme heat or cold, and when affected by pathogens or endemic illnesses such as malaria. China is reportedly conducting similar research.
5. Using blood banks to create a universal donor blood
Researchers at Japan's Nara Medical University began testing artificial hemoglobin in humans in March 2025. Scientists there are harvesting hemoglobin from unused blood bank reserves. They are efficient in transporting oxygen and can be used with any blood type. Initial data was published in the June issue of the Journal of Artificial Organs. The report said that some test persons developed a slight fever but that the results were so promising that researchers are hoping to make the method available for use by 2030.
All of these approaches are being pursued at great pace. Yet, it will still be years before safe artificial blood can be produced at scale.
Until then, human blood donations remain essential for transfusions to continue.
This article was originally written in German and translated by Jon Shelton.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
DW
a day ago
- DW
Can lab-made blood make up for global shortages? – DW – 06/13/2025
Many countries lack blood donors. The quest to create an artificial, lab-made blood type that could make up for supply shortages is extremely difficult. But there are some technologies that offer hope. Blood reserves are in short supply around the world. According to the World Health Organization (WHO), blood donation services in many countries are simply unable to meet demands for collecting and storing healthy blood. Germany's Red Cross (DRK) estimates that some 112 million annual donations are required to cover the need. The DRK adds that one blood donation can be enough to help up to three injured or extremely ill patients. Blood donations, however, vary greatly according to national wealth, with 40% of 118.5 million annual donations coming from high-income countries that make up only 16% of the world's population. Yet, even wealthy countries constantly need to draw from and replenish their blood banks. Germany alone uses some 15,000 units of blood each day. Often, even promises of money, gifts or vouchers are not enough to encourage donor participation. Animal blood not (yet) an alternative Although animal blood could theoretically be used in human transfusions if successfully altered with the use of gene-editing technology, the impediments to getting there are incredibly complex. Animal blood cells are significantly different from human blood cells, especially regarding surface structure. The human immune system would immediately recognize non-altered animal blood cells as foreign and reject them. That is why all immune-related antigens would have to be removed or human antigens added, a highly complicated procedure. These issues have rendered the potential use of animal blood for human transfusions unrealistic in the near future. The quest to create a new, universal blood type At the moment, different approaches to finding a solution to blood shortages are being taken by scientists around the world. Researchers have, for instance, altered blood stem cells, also known as hematopoietic stem cells or HSCs, in ways that allow them to transport more oxygen. They have developed enzymes to neutralize blood type, doing away with the problem of compatibility. Artificial, longer-lasting red blood cells are being developed, too. But the promise of blood substitutes also comes with considerable risk. Such blood can trigger potentially deadly anaphylactic reactions when, for example, the immune system recognizes foreign enzymes or elements contained in artificial blood. Any such blood substitute must replicate all of the functions of biological blood and be universally compatible — similar to naturally occurring Type O blood, which is considered a "universal donor" type. What is your blood made of? Where is it formed? To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video The most promising research approaches so far Several methods for producing lab-made blood are nearly ready for use; others need more trials, including human testing, to ensure such new blood products are safe. Here, a list of five top prospects: 1. Genetically modifying red blood cells Researchers at Stanford University and the University of California San Francisco (UCSF) have used CRISPR gene-editing technology to develop a new method for altering bone marrow stem cells in a way that increases their production of hemoglobin in red blood cells, allowing these to carry more oxygen. So far, returns have been modest when compared to biological blood, with researchers only producing roughly 1% of the hemoglobin that a donor would. Still, when the team's trial was completed with no complications or side-effects to participants, it was celebrated as a medical breakthrough. 2. Neutralizing blood type with gut bacteria enzymes In Denmark and Sweden, scientists have found an enzyme in intestinal bacteria that can remove particular elements from blood cells, namely the ABO blood type antigens that determine the different biological blood groups, among them A and B. When these determiners are removed, blood cells become Type O, meaning they can be used for almost every possible patient. Still, until now scientists have been unable to remove the determiners in their entirety, leaving small traces behind and thus posing a risk of allergic reaction in some individuals. Another major hurdle is the removal of the so-called rhesus factor — a surface protein key in determining blood compatibility. 3. Nano RBCs: Microscopic artificial blood cells Researchers at Penn State University in the US are currently producing tiny, artificial red blood cells (RBC) that function just like the real thing. Although nano-RBCs are only one-tenth the size of normal blood cells they can transport just as much oxygen. These little cells are extremely flexible and can even move through small blood vessels. They would also seem ideally suited for emergency situations and natural catastrophes as they can be stored at room temperature for long periods of time. 4. Military application for enhanced performance The US military is backing research that loads up red blood cells with special nanoparticles. The Pentagon's Defense Advanced Research Projects Agency, better known as DARPA, is creating what it calls a "Red Blood Cell Factory" that will help soldiers cope with lack of oxygen at altitude, in extreme heat or cold, and when affected by pathogens or endemic illnesses such as malaria. China is reportedly conducting similar research. 5. Using blood banks to create a universal donor blood Researchers at Japan's Nara Medical University began testing artificial hemoglobin in humans in March 2025. Scientists there are harvesting hemoglobin from unused blood bank reserves. They are efficient in transporting oxygen and can be used with any blood type. Initial data was published in the June issue of the Journal of Artificial Organs. The report said that some test persons developed a slight fever but that the results were so promising that researchers are hoping to make the method available for use by 2030. All of these approaches are being pursued at great pace. Yet, it will still be years before safe artificial blood can be produced at scale. Until then, human blood donations remain essential for transfusions to continue. This article was originally written in German and translated by Jon Shelton.
DW
a day ago
- DW
What's the big deal with rare earth elements? – DW – 06/13/2025
What do EVs, fighter jets and digital cameras have in common? Rare earth elements that are wanted everywhere but only sourced in some places. Rare earth elements are a group of 17 chemical elements that play an often small but irreplaceable role in many essential modern technological products. Smartphones, flat-screen TVs, digital cameras and LEDs all rely on them but arguably one of their most important uses is in the making of what are known as permanent magnets. These components can retain their magnetic properties for decades, and because they are so strong, they can be much smaller and lighter than any non-rare-earth alternatives currently available. As a result, they are critical to the construction of electric vehicles and wind turbines. But the uses for rare earth elements, also known as REEs, do not stop there. They are also key to a huge range of defense technologies — from fighter jets to submarines and laser range finders. This strategic importance, both for commerce and defense, is part of what makes them so valuable. Neodymium and praseodymium, the most important REEs for permanent magnets, currently go for around €55 ($62) per kilogram. Terbium can sell for a kilo price of up to €850. Neodymium: The metal driving the energy transition To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Where do they come from? The 17 elements are not as 'rare' as their collective name might imply. In fact, they're very common, with trace amounts being found all over the world. The challenge comes in finding areas with high enough concentrations to make extraction financially viable. Right now, according to US Geological Survey data, 70% of the world's rare earth elements are mined in China, the vast majority coming from the Bayan Obi mine in the country's north. This single source is orders of magnitude larger than the next biggest deposits on the planet — such as Mount Weld in Australia and Kvanefjeld in Greenland — and contains large quantities of all the rare earth elements used to make magnets. Once they're out of the ground, they undergo a highly specialized process of separation and refinement to turn them into usable compounds. This too, largely takes place in China, meaning the country doesn't only provide most of the world's rare earth metals, but most of its magnets too. Rare earth elements are shipped in containers of soil such as here at Lianyungang port in China's Jiangsu province Image: REUTERS This monopoly becomes even more powerful with certain types of the 17 REEs, which are split into three groups: light, medium and heavy, roughly based on their atomic value. The lighter elements are typically less valuable and easier to source, with the magnet ingredients Neodymium and Praseodymium being the exceptions. Between 80-100% of the EU's supply of elements from this group come from China. And for the heavier elements, which are much less abundant and require an even more specialized separation process, Europe sources 100% from China. What happens if China cuts off access? China's monopoly has many Western nations concerned about future access. So in recent years, the US and EU have responded by starting the process of building internal supplies of rare earth elements and other critical materials. In 2024, the EU signed the Critical Raw Materials Act, which sets non-binding targets for the volume of critical materials the EU should produce itself by 2030. It also allows the bloc to designate 'strategic projects,' both within the EU and with close allies such as Norway, as a way of to ensure access to funding, boost public acceptance and fast track approvals and permits. Meanwhile, the US defense department has been investing heavily in domestic companies since 2020 and has set a goal of creating an internal 'mine-to-magnet' supply chain by 2027. The US and EU have both expressed interest in untapped sources of rare earth elements. Ukraine and Greenland have become areas of key interest for US President Donald Trump. Both have very large potential deposits that are currently hard to get to, leaving the future of access to rare earth elements for Western countries uncertain. Edited by: Tamsin Walker
DW
3 days ago
- DW
AI art can't match human creativity, yet — researchers – DW – 06/11/2025
Generative AI models are bad at representing things that require human senses, like smell and touch. Their creativity is 'hollow and shallow,' say experts. Anyone can sit down with an artificial intelligence (AI) program, such as ChatGPT, to write a poem, a children's story, or a screenplay. It's uncanny: the results can seem quite "human" at first glance. But don't expect anything with much depth or sensory "richness", as researchers explain in a new study. They found that the Large Language Modes (LLMs) that currently power Generative AI tools are unable to represent the concept of a flower in the same way that humans do. In fact, the researchers suggest that LLMs aren't very good at representing any 'thing' that has a sensory or motor component — because they lack a body and any organic human experience. "A large language model can't smell a rose, touch the petals of a daisy or walk through a field of wildflowers. Without those sensory and motor experiences, it can't truly represent what a flower is in all its richness. The same is true of some other human concepts," said Qihui Xu, lead author of the study at Ohio State University, US. The study suggests that AI's poor ability to represent sensory concepts like flowers might also explain why they lack human-style creativity. "AI doesn't have rich sensory experiences, which is why AI frequently produces things that satisfy a kind of minimal definition of creativity, but it's hollow and shallow," said Mark Runco, a cognitive scientist at Southern Oregon University, US, who was not involved in the study. The study was published in the journal Nature Human Behaviour , June 4, 2025. What are the challenges to book preservation? To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video AI poor at representing sensory concepts The more scientists probe the inner workings of AI models, the more they are finding just how different their 'thinking' is compared to that of humans. Some say AIs are so different that they are more like alien forms of intelligence. Yet objectively testing the conceptual understanding of AI is tricky. If computer scientists open up a LLM and look inside, they won't necessarily understand what the millions of numbers changing every second really mean. Xu and colleagues aimed to test how well LLMs can 'understand' things based on sensory characteristics. They did this by testing how well LLMs represent words with complex sensory meanings, measuring factors, such as how emotionally arousing a thing is or whether you can mentally visualize a thing, and movement or action-based representations. For example, they analyzed the extent to which humans experience flowers by smelling, or experience them using actions from the torso, such as reaching out to touch a petal. These ideas are easy for us to grasp, since we have intimate knowledge of our noses and bodies, but it's harder for LLMs, which lack a body. Overall, LLMs represent words well — but those words lack any connection to the senses or motor actions that we experience or feel as humans. But when it comes to words that have connections to things we see, taste or interact with using our body, that's where AI fails to convincingly capture human concepts. What's meant by 'AI art is hollow' AI creates representations of concepts and words by analyzing patterns from a dataset that is used to train it. This idea underlies every algorithm or task, from writing a poem, to predicting whether an image of a face is you or your neighbor. Most LLMs are trained on text data scraped from the internet, but some LLMs are also trained on visual learning, from still-images and videos. Xu and colleagues found that LLMs with visual learning exhibited some similarity with human representations in visual-related dimensions. Those LLMs beat other LLMs trained just on text. But this test was limited to visual learning — it excluded other human sensations, like touch or hearing. This suggests that the more sensory information an AI model receives as training data, the better it can represent sensory aspects. AI's impact on the working world To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video AI keeps learning and improving The authors noted that LLMs are continually improving and said it was likely that AI will get better at capturing human concepts in the future. Xu said that when future LLMs are augmented with sensor data and robotics, they may be able to actively make inferences about and act upon the physical world. But independent experts DW spoke to suggested the future of sensory AI remained unclear. "It's possible an AI trained on multisensory information could deal with multimodal sensory aspects without any problem," said Mirco Musolesi, a computer scientist at University College London, UK, who was not involved in the study. However, Runco said even with more advanced sensory capabilities, AI will still understand things like flowers completely differently to humans. Our human experience and memory are tightly linked with our senses — it's a brain-body interaction that stretches beyond the moment. The smell of a rose or the silky feel of its petals, for example, can trigger joyous memories of your childhood or lustful excitement in adulthood. AI programs do not have a body, memories or a 'self'. They lack the ability to experience the world or interact with it as animals and human-animals do — which, said Runco, means "the creative output of AI will still be hollow and shallow." Edited by: Zulfikar Abbany
